Insider Transactions in Q3 2023 at Azenta, Inc. (AZTA)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 11
2023
|
David C Gray Chief Strategy & New Business |
SELL
Open market or private sale
|
Direct |
10,877
-12.37%
|
$609,112
$56.03 P/Share
|
|
Aug 10
2023
|
David C Gray Chief Strategy & New Business |
SELL
Open market or private sale
|
Direct |
4,311
-4.67%
|
$245,727
$57.24 P/Share
|
|
Aug 10
2023
|
Robin Vacha SVP, GM Life Science Products |
SELL
Grant, award, or other acquisition
|
Direct |
7,400
-22.69%
|
$407,000
$55.0 P/Share
|
|
Aug 08
2023
|
Ellen M Zane Director |
SELL
Grant, award, or other acquisition
|
Direct |
18,766
-31.33%
|
$1,032,130
$55.78 P/Share
|
|
Jul 31
2023
|
Lindon G Robertson EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
105
+0.09%
|
$4,095
$39.98 P/Share
|
|
Jul 31
2023
|
Ginger Zhou SVP and General Manager, Genom |
BUY
Grant, award, or other acquisition
|
Direct |
54
+0.61%
|
$2,106
$39.98 P/Share
|
|
Jul 31
2023
|
Robin Vacha SVP, GM Life Science Products |
BUY
Grant, award, or other acquisition
|
Direct |
121
+0.37%
|
$4,719
$39.98 P/Share
|